SIC-19 is a SIK2 inhibitor and promotes SIK2 protein degradation via the ubiquitination pathway. SIC-19 inhibits cancer cell growth and sensitizes cells to PARP inhibitors (Such as Olaparib (HY-10162)), as well as in ovarian cancer organoids and xenograft models[1].
Molekulargewicht:
574.67
Reinheit:
98
CAS Nummer:
[713112-69-7]
Formel:
C29H26N4O5S2
Target-Kategorie:
Salt-inducible Kinase (SIK)
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten